{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T05:54:45Z","timestamp":1792907685160,"version":"4.5.0"},"reference-count":65,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T00:00:00Z","timestamp":1692662400000},"content-version":"vor","delay-in-days":1421,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1007\/s13311-019-00762-z","type":"journal-article","created":{"date-parts":[[2019,7,17]],"date-time":"2019-07-17T15:42:38Z","timestamp":1563378158000},"page":"1097-1105","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Molecular Mechanisms and Therapeutics for SCA17"],"prefix":"10.1016","volume":"16","author":[{"given":"Qiong","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongcheng","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Jiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shihua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1007\/s13311-019-00762-z_bib1","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1146\/annurev.neuro.29.051605.113042","article-title":"Trinucleotide repeat disorders","volume":"30","author":"Orr","year":"2007","journal-title":"Annu Rev Neurosci"},{"key":"10.1007\/s13311-019-00762-z_bib2","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1093\/hmg\/8.11.2047","article-title":"A neurological disease caused by an expanded CAG trinucleotide repeat in the TATA-binding protein gene: a new polyglutamine disease?","volume":"8","author":"Koide","year":"1999","journal-title":"Hum Mol Genet"},{"key":"10.1007\/s13311-019-00762-z_bib3","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1093\/hmg\/10.14.1441","article-title":"SCA17, a novel autosomal dominant cerebellar ataxia caused by an expanded polyglutamine in TATA-binding protein","volume":"10","author":"Nakamura","year":"2001","journal-title":"Hum Mol Genet"},{"key":"10.1007\/s13311-019-00762-z_bib4","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.parkreldis.2009.06.006","article-title":"Huntington's disease-like and ataxia syndromes: identification of a family with a de novo SCA17\/TBP mutation","volume":"16","author":"Bech","year":"2010","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1007\/s13311-019-00762-z_bib5","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/j.1399-0004.2004.00356.x","article-title":"Small de novo duplication in the repeat region of the TATA-box-binding protein gene manifest with a phenotype similar to variant Creutzfeldt-Jakob disease","volume":"66","author":"Shatunov","year":"2004","journal-title":"Clin Genet"},{"key":"10.1007\/s13311-019-00762-z_bib6","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1093\/brain\/124.10.1939","article-title":"CAG repeat expansion in the TATA box-binding protein gene causes autosomal dominant cerebellar ataxia","volume":"124","author":"Fujigasaki","year":"2001","journal-title":"Brain"},{"key":"10.1007\/s13311-019-00762-z_bib7","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/sj.ejhg.5201954","article-title":"Instability of expanded CAG\/CAA repeats in spinocerebellar ataxia type 17","volume":"16","author":"Gao","year":"2008","journal-title":"Eur J Hum Genet"},{"key":"10.1007\/s13311-019-00762-z_bib8","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1212\/01.WNL.0000094123.09098.A0","article-title":"Intergenerational instability and marked anticipation in SCA-17","volume":"61","author":"Maltecca","year":"2003","journal-title":"Neurology"},{"key":"10.1007\/s13311-019-00762-z_bib9","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1001\/archneur.61.8.1314","article-title":"Behavioral disorder, dementia, ataxia, and rigidity in a large family with TATA box-binding protein mutation","volume":"61","author":"Bruni","year":"2004","journal-title":"Arch Neurol"},{"key":"10.1007\/s13311-019-00762-z_bib10","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/ana.10676","article-title":"Clinical features and neuropathology of autosomal dominant spinocerebellar ataxia (SCA17)","volume":"54","author":"Rolfs","year":"2003","journal-title":"Ann Neurol"},{"key":"10.1007\/s13311-019-00762-z_bib11","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1002\/(SICI)1096-8628(19960920)67:5<495::AID-AJMG12>3.0.CO;2-I","article-title":"Analysis of polyglutamine-coding repeats in the TATA-binding protein in different human populations and in patients with schizophrenia and bipolar affective disorder","volume":"67","author":"Rubinsztein","year":"1996","journal-title":"Am J Med Genet"},{"key":"10.1007\/s13311-019-00762-z_bib12","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.parkreldis.2015.11.011","article-title":"A patient with 41 CAG repeats in SCA17 presenting with parkinsonism and chorea","volume":"22","author":"Park","year":"2016","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1007\/s13311-019-00762-z_bib13","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s40673-018-0086-x","article-title":"Spinocerebellar ataxia 17: full phenotype in a 41 CAG\/CAA repeats carrier","volume":"5","author":"Origone","year":"2018","journal-title":"Cerebellum Ataxias"},{"key":"10.1007\/s13311-019-00762-z_bib14","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1002\/mds.21275","article-title":"Case of spinocerebellar ataxia type 17 (SCA17) associated with only 41 repeats of the TATA-binding protein (TBP) gene","volume":"22","author":"Nanda","year":"2007","journal-title":"Mov Disord"},{"key":"10.1007\/s13311-019-00762-z_bib15","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.parkreldis.2014.03.007","article-title":"Psychiatric onset and late chorea in a patient with 41 CAG repeats in the TATA-binding protein gene","volume":"20","author":"Alibardi","year":"2014","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1007\/s13311-019-00762-z_bib16","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/mds.25770","article-title":"Late onset ataxia: MSA-C or SCA 17? A gene penetrance dilemma","volume":"29","author":"Doherty","year":"2014","journal-title":"Mov Disord"},{"key":"10.1007\/s13311-019-00762-z_bib17","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1146\/annurev.bi.65.070196.004005","article-title":"Biochemistry and structural biology of transcription factor IID (TFIID)","volume":"65","author":"Burley","year":"1996","journal-title":"Annu Rev Biochem"},{"key":"10.1007\/s13311-019-00762-z_bib18","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1101\/gad.7.7b.1291","article-title":"TBP, a universal eukaryotic transcription factor?","volume":"7","author":"Hernandez","year":"1993","journal-title":"Genes Dev"},{"key":"10.1007\/s13311-019-00762-z_bib19","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1126\/science.1076327","article-title":"RNA polymerase II transcription in murine cells lacking the TATA binding protein","volume":"298","author":"Martianov","year":"2002","journal-title":"Science"},{"key":"10.1007\/s13311-019-00762-z_bib20","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.1093\/nar\/27.15.3146","article-title":"Analysis of the chicken TBP-like protein(tlp) gene: evidence for a striking conservation of vertebrate TLPs and for a close relationship between vertebrate tbp and tlp genes","volume":"27","author":"Shimada","year":"1999","journal-title":"Nucleic Acids Res"},{"key":"10.1007\/s13311-019-00762-z_bib21","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/0092-8674(90)90681-4","article-title":"Analysis of structure-function relationships of yeast TATA box binding factor TFIID","volume":"61","author":"Horikoshi","year":"1990","journal-title":"Cell"},{"key":"10.1007\/s13311-019-00762-z_bib22","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0968-0004(03)00117-8","article-title":"The genetics of TBP and TBP-related factors","volume":"28","author":"Davidson","year":"2003","journal-title":"Trends Biochem Sci"},{"key":"10.1007\/s13311-019-00762-z_bib23","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0092-8674(02)00648-7","article-title":"A regulated two-step mechanism of TBP binding to DNA: a solvent-exposed surface of TBP inhibits TATA box recognition","volume":"108","author":"Zhao","year":"2002","journal-title":"Cell"},{"key":"10.1007\/s13311-019-00762-z_bib24","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/j.1440-1789.2000.00354.x","article-title":"Pathology of CAG repeat diseases","volume":"20","author":"Yamada","year":"2000","journal-title":"Neuropathology"},{"key":"10.1007\/s13311-019-00762-z_bib25","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/978-3-319-71779-1_10","article-title":"Spinocerebellar Ataxia Type 17 (SCA17)","volume":"1049","author":"Toyoshima","year":"2018","journal-title":"Adv Exp Med Biol"},{"key":"10.1007\/s13311-019-00762-z_bib26","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1093\/brain\/awr146","article-title":"Neuronal expression of TATA box-binding protein containing expanded polyglutamine in knock-in mice reduces chaperone protein response by impairing the function of nuclear factor-Y transcription factor","volume":"134","author":"Huang","year":"2011","journal-title":"Brain"},{"key":"10.1007\/s13311-019-00762-z_bib27","doi-asserted-by":"crossref","first-page":"9068","DOI":"10.1523\/JNEUROSCI.5622-12.2013","article-title":"A novel transgenic rat model for spinocerebellar ataxia type 17 recapitulates neuropathological changes and supplies in vivo imaging biomarkers","volume":"33","author":"Kelp","year":"2013","journal-title":"J Neurosci"},{"key":"10.1007\/s13311-019-00762-z_bib28","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1038\/nn2011","article-title":"Polyglutamine domain modulates the TBP-TFIIB interaction: implications for its normal function and neurodegeneration","volume":"10","author":"Friedman","year":"2007","journal-title":"Nat Neurosci"},{"key":"10.1007\/s13311-019-00762-z_bib29","doi-asserted-by":"crossref","first-page":"3424","DOI":"10.1093\/hmg\/ddr251","article-title":"A Drosophila model of the neurodegenerative disease SCA17 reveals a role of RBP-J\/Su(H) in modulating the pathological outcome","volume":"20","author":"Ren","year":"2011","journal-title":"Hum Mol Genet"},{"key":"10.1007\/s13311-019-00762-z_bib30","doi-asserted-by":"crossref","first-page":"8283","DOI":"10.1074\/jbc.M709674200","article-title":"Polyglutamine expansion reduces the association of TATA-binding protein with DNA and induces DNA binding-independent neurotoxicity","volume":"283","author":"Friedman","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1007\/s13311-019-00762-z_bib31","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.celrep.2015.08.060","article-title":"Large Polyglutamine Repeats Cause Muscle Degeneration in SCA17 Mice","volume":"13","author":"Huang","year":"2015","journal-title":"Cell Rep"},{"key":"10.1007\/s13311-019-00762-z_bib32","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.neuron.2013.12.002","article-title":"Age-dependent decrease in chaperone activity impairs MANF expression, leading to Purkinje cell degeneration in inducible SCA17 mice","volume":"81","author":"Yang","year":"2014","journal-title":"Neuron"},{"key":"10.1007\/s13311-019-00762-z_bib33","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/nature02998","article-title":"Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death","volume":"431","author":"Arrasate","year":"2004","journal-title":"Nature"},{"key":"10.1007\/s13311-019-00762-z_bib34","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/ng1977","article-title":"Duplication of Atxn1l suppresses SCA1 neuropathology by decreasing incorporation of polyglutamine-expanded ataxin-1 into native complexes","volume":"39","author":"Bowman","year":"2007","journal-title":"Nat Genet"},{"key":"10.1007\/s13311-019-00762-z_bib35","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0092-8674(00)81782-1","article-title":"Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions","volume":"95","author":"Saudou","year":"1998","journal-title":"Cell"},{"key":"10.1007\/s13311-019-00762-z_bib36","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0092-8674(00)81781-X","article-title":"Ataxin-1 nuclear localization and aggregation: role in polyglutamine-induced disease in SCA1 transgenic mice","volume":"95","author":"Klement","year":"1998","journal-title":"Cell"},{"key":"10.1007\/s13311-019-00762-z_bib37","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/j.1471-4159.2011.07304.x","article-title":"Neuroprotective effects of granulocyte-colony stimulating factor in a novel transgenic mouse model of SCA17","volume":"118","author":"Chang","year":"2011","journal-title":"J Neurochem"},{"key":"10.1007\/s13311-019-00762-z_bib38","doi-asserted-by":"crossref","first-page":"9101","DOI":"10.1523\/JNEUROSCI.0111-17.2017","article-title":"Synergistic Toxicity of Polyglutamine-Expanded TATA-Binding Protein in Glia and Neuronal Cells: Therapeutic Implications for Spinocerebellar Ataxia 17","volume":"37","author":"Yang","year":"2017","journal-title":"J Neurosci"},{"key":"10.1007\/s13311-019-00762-z_bib39","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.bbr.2013.04.042","article-title":"Automated home cage assessment shows behavioral changes in a transgenic mouse model of spinocerebellar ataxia type 17","volume":"250","author":"Portal","year":"2013","journal-title":"Behav Brain Res"},{"key":"10.1007\/s13311-019-00762-z_bib40","doi-asserted-by":"crossref","DOI":"10.1177\/1073858418822993","article-title":"The Expanding Clinical Universe of Polyglutamine Disease.","author":"Huang","year":"2019","journal-title":"Neuroscientist"},{"key":"10.1007\/s13311-019-00762-z_bib41","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/nsb0994-621","article-title":"2.1 A resolution refined structure of a TATA box-binding protein (TBP)","volume":"1","author":"Nikolov","year":"1994","journal-title":"Nat Struct Biol"},{"key":"10.1007\/s13311-019-00762-z_bib42","doi-asserted-by":"crossref","first-page":"4141","DOI":"10.1093\/hmg\/ddp363","article-title":"Transcriptional dysregulation of TrkA associates with neurodegeneration in spinocerebellar ataxia type 17","volume":"18","author":"Shah","year":"2009","journal-title":"Hum Mol Genet"},{"key":"10.1007\/s13311-019-00762-z_bib43","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1101\/gad.1436506","article-title":"Polyglutamine neurodegenerative diseases and regulation of transcription: assembling the puzzle","volume":"20","author":"Riley","year":"2006","journal-title":"Genes Dev"},{"key":"10.1007\/s13311-019-00762-z_bib44","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/nrm3270","article-title":"The unfolded protein response: controlling cell fate decisions under ER stress and beyond","volume":"13","author":"Hetz","year":"2012","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1007\/s13311-019-00762-z_bib45","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.neuro.2018.06.009","article-title":"The indole compound NC009-1 inhibits aggregation and promotes neurite outgrowth through enhancement of HSPB1 in SCA17 cells and ameliorates the behavioral deficits in SCA17 mice","volume":"67","author":"Chen","year":"2018","journal-title":"Neurotoxicology"},{"key":"10.1007\/s13311-019-00762-z_bib46","first-page":"132","article-title":"Targeting the prodromal stage of spinocerebellar ataxia type 17 mice: G-CSF in the prevention of motor deficits via upregulating chaperone and autophagy levels","volume":"2016","author":"Chang","year":"1639","journal-title":"Brain Res"},{"key":"10.1007\/s13311-019-00762-z_bib47","doi-asserted-by":"crossref","first-page":"986","DOI":"10.18632\/aging.101804","article-title":"Shaoyao Gancao Tang (SG-Tang), a formulated Chinese medicine, reduces aggregation and exerts neuroprotection in spinocerebellar ataxia type 17 (SCA17) cell and mouse models","volume":"11","author":"Chen","year":"2019","journal-title":"Aging (Albany NY)"},{"key":"10.1007\/s13311-019-00762-z_bib48","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.neuroscience.2016.03.064","article-title":"BIIB021, a synthetic Hsp90 inhibitor, induces mutant ataxin-1 degradation through the activation of heat shock factor 1","volume":"327","author":"Ding","year":"2016","journal-title":"Neuroscience"},{"key":"10.1007\/s13311-019-00762-z_bib49","doi-asserted-by":"crossref","first-page":"e1003781","DOI":"10.1371\/journal.pgen.1003781","article-title":"Hsp104 suppresses polyglutamine-induced degeneration post onset in a drosophila MJD\/SCA3 model","volume":"9","author":"Cushman-Nick","year":"2013","journal-title":"PLoS Genet"},{"key":"10.1007\/s13311-019-00762-z_bib50","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.nbd.2008.10.016","article-title":"In vivo suppression of polyglutamine neurotoxicity by C-terminus of Hsp70-interacting protein (CHIP) supports an aggregation model of pathogenesis","volume":"33","author":"Williams","year":"2009","journal-title":"Neurobiol Dis"},{"key":"10.1007\/s13311-019-00762-z_bib51","doi-asserted-by":"crossref","first-page":"9651","DOI":"10.1523\/JNEUROSCI.0833-09.2009","article-title":"Mesencephalic astrocyte-derived neurotrophic factor is neurorestorative in rat model of Parkinson's disease","volume":"29","author":"Voutilainen","year":"2009","journal-title":"J Neurosci"},{"key":"10.1007\/s13311-019-00762-z_bib52","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13024-018-0236-x","article-title":"Piperine ameliorates SCA17 neuropathology by reducing ER stress","volume":"13","author":"Guo","year":"2018","journal-title":"Mol Neurodegener"},{"key":"10.1007\/s13311-019-00762-z_bib53","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1111\/jre.12262","article-title":"Piperine inhibit inflammation, alveolar bone loss and collagen fibers breakdown in a rat periodontitis model","volume":"50","author":"Dong","year":"2015","journal-title":"J Periodontal Res"},{"key":"10.1007\/s13311-019-00762-z_bib54","doi-asserted-by":"crossref","first-page":"R49","DOI":"10.1186\/ar2662","article-title":"Anti-inflammatory and antiarthritic effects of piperine in human interleukin 1beta-stimulated fibroblast-like synoviocytes and in rat arthritis models","volume":"11","author":"Bang","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"10.1007\/s13311-019-00762-z_bib55","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1007\/s11064-015-1530-4","article-title":"Trehalose attenuates the gait ataxia and gliosis of spinocerebellar ataxia type 17 mice","volume":"40","author":"Chen","year":"2015","journal-title":"Neurochem Res"},{"key":"10.1007\/s13311-019-00762-z_bib56","first-page":"723","article-title":"Treatment with a Ginkgo biloba extract, EGb 761, inhibits excitotoxicity in an animal model of spinocerebellar ataxia type 17","volume":"10","author":"Huang","year":"2016","journal-title":"Drug Des Devel Ther"},{"key":"10.1007\/s13311-019-00762-z_bib57","doi-asserted-by":"crossref","first-page":"R53","DOI":"10.1093\/hmg\/ddv442","article-title":"Gene suppression strategies for dominantly inherited neurodegenerative diseases: lessons from Huntington's disease and spinocerebellar ataxia","volume":"25","author":"Keiser","year":"2016","journal-title":"Hum Mol Genet"},{"key":"10.1007\/s13311-019-00762-z_bib58","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1172\/JCI92087","article-title":"CRISPR\/Cas9-mediated gene editing ameliorates neurotoxicity in mouse model of Huntington's disease","volume":"127","author":"Yang","year":"2017","journal-title":"J Clin Invest"},{"key":"10.1007\/s13311-019-00762-z_bib59","doi-asserted-by":"crossref","first-page":"CT.002","DOI":"10.1212\/WNL.90.15_supplement.CT.002","article-title":"Effects of IONIS-HTTRx in Patients with Early Huntington's Disease, Results of the First HTT-Lowering Drug Trial (CT.002)","volume":"90","author":"Tabrizi","year":"2018","journal-title":"Neurology"},{"key":"10.1007\/s13311-019-00762-z_bib60","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1038\/mt.2013.152","article-title":"Silencing mutant ATXN3 expression resolves molecular phenotypes in SCA3 transgenic mice","volume":"21","author":"Rodriguez-Lebron","year":"2013","journal-title":"Mol Ther"},{"key":"10.1007\/s13311-019-00762-z_bib61","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1126\/scitranslmed.aaf5660","article-title":"An miRNA-mediated therapy for SCA6 blocks IRES-driven translation of the CACNA1A second cistron","volume":"8","author":"Miyazaki","year":"2016","journal-title":"Sci Transl Med"},{"key":"10.1007\/s13311-019-00762-z_bib62","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1038\/mt.2014.108","article-title":"Nonallele specific silencing of ataxin-7 improves disease phenotypes in a mouse model of SCA7","volume":"22","author":"Ramachandran","year":"2014","journal-title":"Mol Ther"},{"key":"10.1007\/s13311-019-00762-z_bib63","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.molcel.2017.09.002","article-title":"The Anti-CRISPR Story: A Battle for Survival","volume":"68","author":"Maxwell","year":"2017","journal-title":"Mol Cell"},{"key":"10.1007\/s13311-019-00762-z_bib64","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.neuron.2014.03.001","article-title":"Muscle expression of mutant androgen receptor accounts for systemic and motor neuron disease phenotypes in spinal and bulbar muscular atrophy","volume":"82","author":"Cortes","year":"2014","journal-title":"Neuron"},{"key":"10.1007\/s13311-019-00762-z_bib65","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.celrep.2014.02.008","article-title":"Peripheral androgen receptor gene suppression rescues disease in mouse models of spinal and bulbar muscular atrophy","volume":"7","author":"Lieberman","year":"2014","journal-title":"Cell Rep"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-019-00762-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13311-019-00762-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923009698?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923009698?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-019-00762-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T06:45:19Z","timestamp":1761806719000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747923009698"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":65,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["S1878747923009698"],"URL":"https:\/\/doi.org\/10.1007\/s13311-019-00762-z","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular Mechanisms and Therapeutics for SCA17","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s13311-019-00762-z","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2019 The American Society for Experimental NeuroTherapeutics, Inc. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}